Browse Category

ASX Updates News 4 December 2025 - 8 December 2025

Telstra (ASX:TLS) Share Price Near 52‑Week High as Senate Scrutiny Meets Bullish Analyst Upgrades – 8 December 2025

Telstra (ASX:TLS) Share Price Near 52‑Week High as Senate Scrutiny Meets Bullish Analyst Upgrades – 8 December 2025

Telstra Group Limited (ASX:TLS) shares are trading just under the A$5 mark on 8 December 2025, leaving Australia’s largest telecom group close to the top of its 52‑week range as investors weigh fresh regulatory scrutiny against a string of earnings beats, share buybacks and upgraded analyst valuations.StockInvest+1 The latest catalyst is a Senate inquiry into Triple Zero reliability, which has pulled Telstra’s emergency‑call performance into the political spotlight at the same time Morningstar has lifted its fair value estimate for the stock and reaffirmed its view of Telstra as a “defensive” compounder under its new Connected Future 30 strategy.ChannelNews+2Morningstar+2 Telstra
Orica Limited (ASX: ORI) Stock Update – 8 December 2025: Record Earnings, Bigger Dividend and Hydrogen Ambitions

Orica Limited (ASX: ORI) Stock Update – 8 December 2025: Record Earnings, Bigger Dividend and Hydrogen Ambitions

All figures in Australian dollars unless stated otherwise. Data current as of 8 December 2025. Orica share price today: near the top of its 52‑week range Orica Limited (ASX: ORI), the mining and infrastructure solutions group best known for explosives and blasting technology, is trading around A$23.90 per share on 8 December 2025. Recent quotes put the day’s range roughly between A$23.61 and A$23.91, with a 52‑week range of about A$14.88 to A$24.82. Investing.com At these levels, Orica’s market capitalisation sits at roughly A$11.2 billion, and the stock is now about 61% above its 52‑week low, reflecting a strong rerating
Wesfarmers (ASX:WES) Share Price, Capital Return and Analyst Forecasts as at 5 December 2025

Wesfarmers (ASX:WES) Share Price, Capital Return and Analyst Forecasts as at 5 December 2025

Wesfarmers Limited (ASX:WES) heads into December 2025 fresh from a record profit, a A$1.7 billion capital return and special dividend, and a flurry of new analyst calls that now mostly argue the stock is fully valued or even a little stretched. Reuters+2Wesfarmers+2 Below is a news-style rundown of where Wesfarmers shares stand today, what just happened with the capital distribution, and how analysts see the outlook for 2026 and beyond. Wesfarmers share price snapshot in early December 2025 Most real‑time feeds are showing Wesfarmers trading around A$81–82 per share in early December, giving the company a market capitalisation of roughly
Fortescue Ltd (ASX: FMG) Share Price, Dividend and Green Energy Outlook – Latest News and Forecasts as of 5 December 2025

Fortescue Ltd (ASX: FMG) Share Price, Dividend and Green Energy Outlook – Latest News and Forecasts as of 5 December 2025

Fortescue Ltd is ending 2025 in a very strange place: profits are down sharply, yet the share price is hovering around record highs. At the same time, the company is scrapping some flagship green hydrogen projects while doubling down on green iron and large‑scale batteries. As of 4–5 December 2025, Fortescue’s share price is trading around A$21.6–A$21.8, just under its 52‑week high of about A$22.03 and miles above its 52‑week low near A$13–14.StockInvest+2StockInvest+2 That’s roughly a 50%+ rebound from the April lows and values the miner at around A$66.5 billion, on a trailing P/E of about 13 and a dividend
CSL Limited (ASX:CSL) Share Price, Buyback and 2026 Outlook: Latest News and Forecasts as at 5 December 2025

CSL Limited (ASX:CSL) Share Price, Buyback and 2026 Outlook: Latest News and Forecasts as at 5 December 2025

CSL Limited’s share price is still nursing some heavy bruises, but under the surface the story in December 2025 is more “complex reboot” than simple “fallen giant”. On 5 December 2025, the ASX healthcare heavyweight is trading near multi‑year lows after a brutal few months of restructuring, a guidance cut and a delayed vaccines spin‑off. At the same time, CSL is ramping up a large on‑market buyback, opening a $1 billion vaccine and antivenom plant in Melbourne and reiterating medium‑term profit growth targets. Global Newsroom | CSL+1 This article pulls together the latest price action, company announcements, analyst forecasts and
ASX Today: 8 Key Things to Know Before the Australian Stock Market Opens on 5 December 2025

ASX Today: 8 Key Things to Know Before the Australian Stock Market Opens on 5 December 2025

The Australian share market heads into Friday 5 December 2025 with futures signaling a modestly positive or flat open, after a resource‑ and bank‑led rally on Thursday and a mixed but generally constructive lead from Wall Street. Here’s a detailed look at what’s driving sentiment before the ASX opens. 1. ASX 200 futures point to a slightly firmer – but still cautious – open Pre‑market updates suggest the S&P/ASX 200 is set to open slightly higher or largely unchanged: Taken together, the futures picture is one of modest optimism rather than a breakout: traders are watching whether Thursday’s rotation into banks and resources
Aristocrat Leisure (ASX: ALL) Stock Update – 4 December 2025: Price Action, Earnings Strength and ESG Momentum

Aristocrat Leisure (ASX: ALL) Stock Update – 4 December 2025: Price Action, Earnings Strength and ESG Momentum

Aristocrat Leisure Limited (ASX: ALL) remains one of the most closely watched names on the ASX 200, and as of 4 December 2025 the story is a classic market puzzle: robust earnings and dividends, a growing digital strategy and strong ESG messaging on one side, against valuation concerns and uncertainty in online gaming execution on the other. This article pulls together the latest share price moves, full‑year results, sustainability updates, analyst calls and short‑term trading forecasts as at 4 December 2025. Where the Aristocrat share price stands on 4 December 2025 Aristocrat shares are trading around A$57.9 intraday on 4
CSL Limited (ASX:CSL) Share Price on 4 December 2025: Restructuring Fallout, New Vaccine Plant and 2026 Stock Forecast

CSL Limited (ASX:CSL) Share Price on 4 December 2025: Restructuring Fallout, New Vaccine Plant and 2026 Stock Forecast

Updated: 4 December 2025 CSL Limited (ASX:CSL), the Australian biotech heavyweight, is trading around A$183 per share on 4 December 2025 after one of the most bruising years in its modern history. The company has delivered solid profit growth, announced thousands of job cuts, delayed a major spin‑off, launched a A$750 million buy‑back and opened a A$1 billion cell‑based vaccine and antivenom plant in Melbourne – all while its share price has fallen by roughly a third. Intelligent Investor+2Global Newsroom | CSL+2 Against that backdrop, investors are trying to decide whether CSL is now a long‑term bargain or a restructuring
ARB Corporation Limited (ASX:ARB) Share Price, Latest Announcements and 2026 Outlook – 4 December 2025

ARB Corporation Limited (ASX:ARB) Share Price, Latest Announcements and 2026 Outlook – 4 December 2025

Published: 4 December 2025 – All figures in AUD unless stated otherwise. ARB Corporation (ASX:ARB) share price today ARB Corporation Limited (ASX:ARB), the 4×4 accessories manufacturer behind the ARB brand, is trading around $32.8–$33.0 per share on 4 December 2025, near the lower half of its 52‑week range of $27.15 to $41.96.Investing.com+1 This puts ARB’s market capitalisation at roughly $2.7–$2.8 billion, based on around 83–84 million shares on issue.StockAnalysis+2Market Index+2 Over the past 12 months, the share price has fallen a little over 20%, underperforming both the broader ASX 200 and the consumer discretionary sector.TradingView+2Intelligent Investor+2 The slide has been
Santos Limited (ASX: STO) Share Price, Takeover Fallout and 2026 Outlook – 4 December 2025

Santos Limited (ASX: STO) Share Price, Takeover Fallout and 2026 Outlook – 4 December 2025

Updated: 4 December 2025 – Not investment advice. Do your own research. Santos share price today and key valuation metrics Santos Limited (ASX: STO) is trading just below A$6.60 per share on 4 December 2025, after drifting sideways to slightly lower since the collapse of a proposed $18.7 billion takeover earlier in the year. Historical data for 4 December shows a close around A$6.60, with recent days oscillating in a tight A$6.50–6.65 band. Investing.com+1 Over the last year, Santos has been a mild underperformer versus the broader Australian market, with the share price down by low single digits while the
Pilbara Minerals (ASX: PLS) Stock Outlook on 4 December 2025: PLS Group Rebrand, Lithium Rebound and Heavy Short Interest

Pilbara Minerals (ASX: PLS) Stock Outlook on 4 December 2025: PLS Group Rebrand, Lithium Rebound and Heavy Short Interest

Pilbara Minerals Limited – now rebranding as PLS Group Limited – sits at the centre of the global lithium story as 2025 draws to a close. The ASX‑listed lithium producer has bounced hard from last year’s slump, is reshaping its corporate identity, and remains one of the most heavily shorted large‑cap stocks in Australia. That mix of strong operations, volatile commodity prices and divisive valuation is exactly what makes Pilbara Minerals (ASX: PLS) one of the most closely watched names on the market. As of early trade around 4 December 2025, PLS is changing hands close to A$3.8–A$3.9 per share,
Macquarie Group (ASX: MQG) Stock on 4 December 2025: Dividend Update, Qube Bid and 2026 Outlook

Macquarie Group (ASX: MQG) Stock on 4 December 2025: Dividend Update, Qube Bid and 2026 Outlook

Snapshot: Macquarie shares steady as big strategic moves land Macquarie Group Limited (ASX: MQG) shares were trading around A$195.44 during Thursday’s session on 4 December 2025, up just over 1% intraday as the market absorbed a fresh dividend allocation update, the completed sale of a major asset-management franchise to Nomura, and the ongoing A$11.6 billion bid for logistics operator Qube Holdings. Macquarie+4Market Index+4Reuters+4 The stock is hovering slightly below the ~A$197 level where it has traded for much of the past week, after investors digested mixed half‑year results in November and a string of large strategic deals that are reshaping
1 10 11 12 13 14 16

Stock Market Today

Blackstone (BX) stock price rebounds after Sabre deal as jobs, CPI loom next week

Blackstone (BX) stock price rebounds after Sabre deal as jobs, CPI loom next week

7 February 2026
New York, February 6, 2026, 21:13 EST — Market closed. Blackstone Inc. (BX) shares closed up 2.25% at $129.69 on Friday, after a sharp drop the day before and a bruising week for the sector. The stock was last at $129.65 in late after-hours trading. (StockAnalysis) The swing matters because Blackstone sits in the crosshairs of a wider rethink of private-market managers. Investors have been quick to punish anything tied to leverage, credit risk and tech exposure, then just as quick to buy back when rates and risk appetite settle. That push-pull has been driven in part by an AI-linked
Verizon stock price snaps 7-day run as consumer chief exit sharpens focus on turnaround

Verizon stock price snaps 7-day run as consumer chief exit sharpens focus on turnaround

7 February 2026
Verizon shares fell 1.7% to $46.31 Friday, ending a seven-session rally and closing about 2.7% below Thursday’s one-year high. The dip follows news that consumer chief Sowmyanarayan Sampath will step down, with Alfonso Villanueva named interim head. Verizon has climbed 16% since January 29 amid strong subscriber growth and a $25 billion buyback plan.
Cisco stock jumps 3% near $85 as UBS sticks with Buy ahead of Feb. 11 earnings

Cisco stock jumps 3% near $85 as UBS sticks with Buy ahead of Feb. 11 earnings

7 February 2026
Cisco shares rose 3% to $84.82 Friday, nearing $85 ahead of fiscal Q2 results due Feb. 11. UBS maintained a Buy rating and $90 target, citing strong product order growth and data-center demand. Investors are watching AI-related spending and U.S. economic data that could affect rates. Peers Fortinet, CrowdStrike, and Palo Alto Networks also gained.
Go toTop